Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis

NCT02129777 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
122
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda